Skip to main content

Schonfeld Strategic Advisors LLC

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 1665241 NEW YORK, NY

Position in TERN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
165,725
-78.0% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TERN Over Time

Shares Held

Position Value (USD)

Derivatives in TERN

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
50,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in TERN

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 50,000
2026-03-31 165,725
2025-12-31 754,237
2025-09-30 1,891,925
2025-06-30 3,049,891
2025-03-31 3,844,867
2025-03-31 $11,882,363 4,305,204
2024-12-31 4,751,506
2024-09-30 3,289,826
2024-06-30 2,268,428
2024-03-31 1,195,794
2023-12-31 407,858
2023-09-30 91,408
2023-06-30 118,936
2023-03-31 115,252